Integral Diagnostics Limited
ITGDF
$0.98
-$1.05-51.78%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2,378.91% | 2,308.29% | -18.65% | -20.17% | 99.41% |
| Total Depreciation and Amortization | 57.99% | 53.16% | 39.96% | 37.34% | 2.96% |
| Total Amortization of Deferred Charges | -- | -- | 22.90% | 20.60% | -- |
| Total Other Non-Cash Items | -992.20% | -958.93% | -98.17% | -98.20% | -102.03% |
| Change in Net Operating Assets | -- | -- | 194.13% | 188.62% | -- |
| Cash from Operations | 50.86% | 46.25% | -1.54% | -3.39% | 44.16% |
| Capital Expenditure | 6.78% | 9.62% | -164.08% | -159.12% | -128.25% |
| Sale of Property, Plant, and Equipment | 2.65% | -0.48% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 470.85% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 22.97% | 25.33% | -162.13% | -157.22% | -103.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 96.55% | 96.55% | -16.35% | -16.35% | -3,801.26% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -83.96% | -78.34% | -69.84% | -66.66% | -0.06% |
| Other Financing Activities | 5.71% | 5.71% | 179.31% | 179.31% | -826.44% |
| Cash from Financing | -2,676.32% | -2,591.86% | 111.42% | 111.21% | 94.02% |
| Foreign Exchange rate Adjustments | -791.44% | -761.51% | 155.96% | 154.91% | -135.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.08% | -57.13% | -17.14% | -18.69% | 29.58% |